Skip to main navigation Skip to search Skip to main content

Magnetic PiezoBOTs: a microrobotic approach for targeted amyloid protein dissociation

  • Shen Ning
  • , Roger Sanchis-Gual
  • , Carlos Franco*
  • , Pedro D. Wendel-Garcia
  • , Hao Ye
  • , Andrea Veciana
  • , Qiao Tang
  • , Semih Sevim
  • , Lukas Hertle
  • , Joaquin Llacer-Wintle
  • , Xiao Hua Qin
  • , Caihong Zhu
  • , Jun Cai
  • , Xiangzhong Chen
  • , Bradley J. Nelson
  • , Josep Puigmartí-Luis*
  • , Salvador Pané*
  • *Corresponding author for this work
  • Boston University
  • Swiss Federal Institute of Technology Zurich
  • University of Zurich
  • Fudan University
  • University of Barcelona
  • ICREA

Research output: Contribution to journalArticlepeer-review

Abstract

Piezoelectric nanomaterials have become increasingly popular in the field of biomedical applications due to their high biocompatibility and ultrasound-mediated piezocatalytic properties. In addition, the ability of these nanomaterials to disaggregate amyloid proteins, which are responsible for a range of diseases resulting from the accumulation of these proteins in body tissues and organs, has recently gained considerable attention. However, the use of nanoparticles in biomedicine poses significant challenges, including targeting and uncontrolled aggregation. To address these limitations, our study proposes to load these functional nanomaterials on a multifunctional mobile microrobot (PiezoBOT). This microrobot is designed by coating magnetic and piezoelectric barium titanate nanoparticles on helical biotemplates, allowing for the combination of magnetic navigation and ultrasound-mediated piezoelectric effects to target amyloid disaggregation. Our findings demonstrate that acoustically actuated PiezoBOTs can effectively reduce the size of aggregated amyloid proteins by over 80% in less than 10 minutes by shortening and dissociating constituent amyloid fibrils. Moreover, the PiezoBOTs can be easily magnetically manipulated to actuate the piezocatalytic nanoparticles to specific amyloidosis-affected tissues or organs, minimizing side effects. These biocompatible PiezoBOTs offer a promising non-invasive therapeutic approach for amyloidosis diseases by targeting and breaking down protein aggregates at specific organ or tissue sites.

Original languageEnglish
Pages (from-to)14800-14808
Number of pages9
JournalNanoscale
Volume15
Issue number36
DOIs
StatePublished - 18 Aug 2023

Fingerprint

Dive into the research topics of 'Magnetic PiezoBOTs: a microrobotic approach for targeted amyloid protein dissociation'. Together they form a unique fingerprint.

Cite this